image/svg+xml

What is automated blood testing?

Home | FAQ | What is automated blood testing?

Automation in the laboratory

Clinical laboratories began to discover laboratory automation around 1960, and innovation and the evolution of clinical laboratory instruments were part of the development of the laboratory automation process.

Over the years, many improvements were made in laboratories’ information management systems, the principal goal being to facilitate the transfer of patient information to healthcare professionals and biologists.

Clinical laboratories’ work is organized into three phases: preanalytical, analytical and post-analytical. Most clinical laboratories have now automated the analytical phase, which improves the workflow. And the post-analytical stage is also partially automated to help healthcare practitioners in their decision-making processes.

But up until now only these two of the three phases have been part of the laboratory automation process, with the preanalytical phase not having been automated at all. And this is the potential weak point for errors in laboratories. (improvement of TAT).

Blood test automation

HEIVA will soon be the answer to automating this missing phase by offering a medical robotic solution for blood draw, and will be the missing link in the total laboratory automation revolution. HEIVA will provide standardization in the blood drawing process, the last missing step to full automation of the laboratory automation process.

HEIVA will draw the blood, label the tubes, treat them in the correct order and ensure their traceability. In this way, HEIVA will drastically reduce preanalytical errors and will improve the patient experience.

Contact us

    Be aware that you are accessing a space where you can freely enter information. Please only enter the personal data strictly necessary for the processing of your request for information or your application and refrain from transmitting us any personal data considered sensitive (racial or ethnic origin, political, philosophical or religious opinion, union membership, sexual orientation, or social security number).

    * Required fields

    Stay tuned

    • LinkedIn

    The research and development of the first HEIVA device has been supported from 2018 to 2021 by the European Union via the ERDF to the tune of €1.125M

    The company is supported by the future investment program

    BHealthCare
    • Legal notice
    • Privacy Policy
    • Cookies Policy
    • All rights reserved ©
    BHealthCare
    • HEIVA
    • Advantages
    • Our team
    • Our future
    • News
    • What they are saying about us

    image/svg+xml Contact us!